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Objective:Controlled hypotension is critical for precise deployment of endografts in the thoracic aorta and for safe balloon
dilation after deployment. We describe a novel approach to rapid right ventricular pacing using a pulmonary artery
catheter (PAC) that is placed during the procedure for hemodynamic monitoring.
Methods: The study included 27 patients (20 men and seven women), with a mean age of 74 years, who underwent
endograft placement in the thoracic aorta with PAC-directed rapid right ventricular pacing. Hemodynamic parameters,
accuracy of deployment, complications related to rapid right ventricular pacing and PAC placement, presence of
endoleaks, and postoperative complications were evaluated.
Results: PAC-directed rapid right ventricular pacing was performed during endograft deployment and balloon dilation after
deployment without technical difficulty. Each patient underwent amedian of two pacing episodes (range, 1-4). The length of each
pacing episode was a mean of 11 seconds (range, 8-14 seconds). Mean pacing rate was 170  15 beats/min, which achieved an
averagemean arterial pressure (MAP) of 42 8mmHg. After pacing cessation, the recovery time ofMAP to prepacing levels was
<5 seconds (mean, 2 seconds) in all but one patient. All endografts were precisely deployed at a mean of 2 mm from the intended
placement site, andtherewasnounintentionalbranchvessel coverage.Onepatientwithseverevalvularheartdiseasedied.Therewere
nine endoleaks, one postoperative stroke (4%), and one access wound hematoma (4%).
Conclusions: PAC-directed rapid right ventricular pacing is an effectivemethod of inducing hypotension, enabling precise thoracic
endograft deployment and safe balloon dilation after deployment. However, despite these advantages, the technique may be
















flEndovascular repair using thoracic aortic endografts is
an accepted practice for the treatment of most patients with
thoracic aortic aneurysms.1,2 Despite increasing expertise
and experience with endograft deployment in the thoracic
aorta, the technical challenges of deploying these devices in
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1196highly angulated aortic arch remain formidable. Adequate
roximal and distal sealing zones in the thoracic aorta are
rerequisites for endograft usage. The length of these seal-
ng zones is often limited if the aneurysm is close to the
ortic arch branches or visceral arteries. Accurate endograft
eployment is necessary to avoid end-organ ischemia and
ndoleaks but is hindered by pulsatile aortic blood flow,
hich causes backward and forward movement of the en-
ografts. Proximal hypertension that develops after partial
ndograft deployment can create a “windsock effect,”
ushing the endograft distally.
Rapid right ventricular (RV) pacing is an alternative
ffective method of lowering aortic flow and pressure,
hereby minimizing the “windsock effect” during en-
ograft deployment in the thoracic aorta. Most reports
ecommend placement of a cardiac pacing catheter under
uoroscopy via right or left femoral vein.3-5 We present our
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accessed by the anesthesiologist during preparation for the
thoracic endovascular aneurysm repair (TEVAR).
METHODS
After Institutional Review Board approval, we reviewed
the clinical records and the radiographic studies of all
consecutive patients for whom we used rapid RV pacing via
a PAC during thoracic endograft placement since we first
initiated this practice at the Mayo Clinic in March 2008.
Twenty-seven patients underwent elective TEVAR for tho-
racic aortic aneurysms. Emergency procedures were ex-
cluded (total of two during the study period). The
clinical, anatomic, and procedural data are presented in
Tables I and II.
The preoperative proximal and distal landing zones,
and the length of the landing zone covered by the en-
Table I. Demographic and clinical characteristics
Characteristic No. (%) or Mean  SD
Men 20 (74)
Women 7 (26)
Age, years 74  11
Weight, kg 84  15
Height, m 1.71  0.08
Symptomatic aneurysm 3 (11)
ASA score, median 3
Smoking 16 (59)
Diabetes mellitus 6 (22)
Hypertension 23 (85)
Hyperlipidemia 14 (52)
Coronary artery disease 12 (44)
COPD 5 (18)
Concomitant aneurysms 9 (38)
Pre-op creatinine, mg/dL 0.97  0.26
ASA, American Society of Anesthesiologists; COPD, chronic obstructive
pulmonary disease; SD, standard deviation.
Table II. Anatomic characteristics and procedural data of
aneurysm repair
Characteristic Result
Aneurysm diameter, mean  SD, mm 65  8
Proximal neck diameter, mean  SD, mm 32  4
Distal neck diameter, median, mm 31  4
Supra-aortic vessel incorporationa 9 (33)
Carotid-subclavian bypass or transposition 5 (15)
Carotid-carotid-subclavian bypass 3 (11)
Ascending aorta-innominate and L carotid bypass 1 (4)
Left subclavian artery fenestration 1 (4)
Elephant trunk reconstruction 1 (4)
Visceral artery incorporation 3 (11)
Celiac fenestration 1 (4)
Celiac and SMA fenestrations 1 (4)
Celiac, SMA and bilateral renal fenestrations 1 (4)
SD, Standard deviation; SMA, superior mesenteric artery.
aMean interval from debranching procedure to endovascular repair was 13
days (2-41).dograft after deployment, were measured by computed Tomography angiography (CTA) using centerline of flow
nalysis. Deployment precision was calculated as the differ-
nce between the available aortic landing zone length on
reoperative CTA and the actual length covered by the
ndograft on the postprocedural CTA.
General anesthesia was used for all procedures. Patients
ere continuously monitored before, during, and after the
ndograft placement, including heart rate, invasive arterial
ressure, and nasopharyngeal temperature. Chest radiograph,
2-lead electrocardiogram (ECG), and troponin levels were
ssessed in all patients immediately after the procedure. All
atientswere neurologically assessed in the recovery roomand
n each postoperative day during their hospital stay.
Description of rapid RV pacing procedure via PAC
nsertion. After induction of general anesthesia and endo-
racheal intubation, an introducer sheath (Arrow Interna-
ional Inc, Reading, Pa) is inserted into the right internal
ugular vein under ultrasound guidance. A PAC with a
acing port is placed through the sheath (Fig 1). Once the
V pressure waveform is obtained in the RV-pacing port
nd a pulmonary artery pressure waveform is demonstrated
n the distal port, the PAC is in position for adequate
onitoring and ventricular pacing. A ventricular pacing
ire is introduced via the RV-pacing port and connected to
he bipolar pacer box. The pacer box is started at an
mplitude of 10 mA and a rate 20 beats faster than the
atient’s baseline heart rate, and the wire is gently advanced
ntil capture occurs. At this time, the pacer box is turned
ff and the wire is confirmed in adequate position for rapid
V pacing. A trial of rapid RV pacing is performed to
valuate the blood pressure drop and heart rate required to
ecrease the systolic blood pressure (SBP) to60 mmHg.
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by 20 beats/min until successful controlled hypotension
(60 mm Hg) is achieved (Fig 2). Recovery of blood
pressure and toleration of rapid RV pacing is also evaluated
at this time. Availability of defibrillator pads is ensured prior
to initial pacing testing.
Rapid RV pacing. Immediately before endograft de-
ployment in the thoracic aorta, the anesthesiologist is
alerted by the vascular surgeon to start rapid RV pacing.
This is achieved at the rate tested when the PAC and
wires were inserted. Graphic display of the effectiveness
of pacing and controlled hypotension is printed and
recorded (Fig 3).
Once the endograft is deployed, the surgeon alerts the
anesthesiologist that is safe to stop pacing.
The ECG and blood pressure are printed and recorded
to document effective, rapid, and controlled recovery of
the patient’s baseline heart rate and blood pressure (Fig
4). The procedure is repeated if needed for deployment
of additional endografts or during balloon molding of
the endograft.
RESULTS
Rapid RV pacing through a PAC was performed with-
Fig 2. Trial of right ventricular pacing after the insertion
wire via the pacing port. First strip: electrocardiogram
pulmonary artery pressure.
Fig 3. Rapid right ventricular pacing during endograft d
(ECG); second strip: arterial blood pressure.out technical difficulty in all 27 patients. The rapid RV zacing was used at the time of the endograft deployment
nd, if necessary, during balloon molding of the endograft.
here were no complications related to PAC placement.
Pacing was achieved at an average heart rate of 170
eats/min and an average mean systolic pressure of 45 mm
g. The mean duration of the pacing episodes was 11
econds. During each pacing episode, an average of 3
econds was required to reduce the mean SBP to goal, and
hemean recovery time, defined as the time required for the
ean arterial pressure to reach pre-pacing levels, was 2
econds. With the exception of the intraoperative death, all
atients experienced recovery 5 seconds of pacing cessa-
ion. A median of two episodes (range, 1-4) was performed
er patient. The procedural characteristics, including the
arameters relevant for the endograft deployment and
apid pacing, are summarized in Table III.
The proximal landing zone for the 27 patients in our
eries is depicted in the diagram in Fig 5. Rapid RV pacing
as used in 23 of 27 patients to facilitate deployment of the
ndograft in the ascending, arch, or proximal descending
horacic aorta, and was used in four patients for accurate
lacement in the distal thoracic aorta near the mesenteric
essels. Deployment precision was calculated for each pa-
ient as the difference between the available aortic landing
e pulmonary artery catheter and placement of the pacing
G); second strip: arterial blood pressure; third strip:
ment in the thoracic aorta. First strip: electrocardiogramof th
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measured on the postprocedure CTA. The precision of
endograft in these 27 patients averaged 2 mm.
After the procedure, the PACwas removed. All patients
were continuously monitored for the first 24 hours and
received a postoperative ECG, and troponin level measure-
ments immediately after the procedure and on the morning
of postoperative day 1. There was one intraoperative death
in a patient with severe mitral regurgitation and moderate
aortic regurgitation that did not recover after multiple
episodes of pacing. Four patients (15%) developed atrial
Fig 4. Recovery of the heart rhythm and blood pressu
endograft deployment.
Table III. Procedural characteristics
Variablea Result
Rapid pacing
Rate, beats/minutes 170  15
Episodes per patient 2 (1-4)
Episode duration, seconds 11  4
MAP during pacing, mm Hg 45  5
Time to achieve goal MAP, seconds 3  1
Proximal/distal neck length
Available, mm 22  5
Covered, mm 20  3
Precision of deployment, mm 2  2
Spinal drain 13 (48)
Intravascular ultrasound 4 (18)
Operative time, minutes 167  48
Estimated blood loss, mL 100  105
Intraoperative transfusion, mL 150  250
MAP, Mean arterial pressure.
aData are mean  SD, standard deviation, median (range), or No. (%).fibrillation with rapid ventricular response after the proce- pure, requiring intensive care unit admission and electric or
harmacologic cardioversion. One patient had troponin
levation (0.01 to 0.1 ng/mL), but was ruled out for
yocardial infarction, and another developed an embolic
troke (4%). No postoperative renal insufficiency was
oted. The median length of stay after the TEVAR proce-
ure was 2 days (range, 1-5). Twenty-six of the 27 patients
ere alive at 30 days. There were nine endoleaks (five type
a, one type Ib, and three type II endoleaks), of which two
equired reintervention. No unintentional branch vessel
overage occurred. The immediate outcome of the patients
n our series is summarized in Table IV.
ISCUSSION
The challenge of endograft displacement caused by
ulsatile blood flow during TEVAR has long been recog-
ized. Controlled hypotension allows exact positioning of
he device during deployment, especially with a short prox-
mal or distal landing zone. The ideal method to induce
ontrolled hypotension should be reliable, easy to perform,
pplicable to most patients, and should not significantly
dd to the duration and complexity of the procedure. In
ddition, the level of hypotension should be predictable, ad-
ustable, and achieved repetitively, if needed. The onset and
ffset of action should be immediatewithminimal side effects.
Previous reports have described rapid RV pacing using
pacing catheter placed via the femoral vein as a safe and
eliable method of reducing pulsatile blood pressure, with
early immediate onset and offset of action.3-5 In addition,
he pacing rate is readily titrated. In our series, the rapid RV
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April 20121200 Ricotta et alogist via the internal jugular vein rather than the femoral
vein. Since a central venous catheter often is placed in the
internal jugular vein in patients undergoing TEVAR for
hemodynamic monitoring and administration of vasoactive
medications, the addition of a PAC does not significantly
increase the complexity and duration of the anesthesia prepa-
Fig 5. Distribution of the proximal landing zone for the deployed
endografts in 24 patients.
Table IV. Thirty-day outcomes
Outcome parameter
No. (%) Mean  SD
median (IQ range)
Total endoleaks 9 (35)
Type Ia 5 (19)
Type Ib 1 (4)
Type II 3 (12)
Complications
PAC-related 0
Atrial fibrillationa 4 (15)
Troponin elevationb 1 (4)
Neurologic (stroke, paraplegia) 1 ( 4)
Access-/wound-related 1 (4)
Hospital length of stay 2 (1-5)
Mortality 1 (4)
IQ, Interquartile range; PAC, pulmonary artery catheter; SD, standard
deviation.
aAtrial fibrillation that required ICU admission and cardioversion (medical
or electrical).
bTransient troponin elevation, myocardial infarction was ruled out.ration time. Moreover, it avoids the need for additional fem- Wral vein access, which has been reported to have a higher
omplication rate than internal jugular vein access.6
Serious complications with temporary cardiac pacing of
hort duration are rare.7 In the absence of a history of
entricular tachycardia or severe heart failure, the risk of a
entricular tachyarrhythmia occurring is 1%. Complica-
ions related to central venous catheterization, including arte-
ial puncture, subcutaneous hematoma, hemothorax, venous
ir embolism, and asystole, are rare in experienced hands.8
omplications related to PAC insertion are also rare but
otentially serious and include ventricular arrhythmias,6 tran-
ient heart block,9 and pulmonary artery perforation.10
In our series, there were no PAC placement complica-
ions. However, one intraoperative death occurred in a
atient with severe valvular disease and moderate left ven-
ricular dysfunction. The patient did not recover after the
hird pacing episode, his rhythm degenerated to ventricular
brillation, and he expired despite defibrillation attempts
nd advanced cardiac life support. Therefore, rapid RV
acing may be contraindicated in patients with impaired
yocardial reserve, or poor tolerance to tachycardia, such
s those with severe coronary artery or valvular heart dis-
ase, or hypertrophic cardiomyopathy.
In the few published reports on this subject,3-5 a right
V pacing catheter is placed under fluoroscopy via the right
r left femoral vein, followed by placement of temporary
acing wires performed in collaboration with a cardiologist.
he method we present uses a PAC positioned in the
tandard fashion at the beginning of the procedure, which
oes not delay endograft placement to allow for right heart
atheterization. Moreover, the anesthesiology team in the
ascular suite is familiar with this equipment. All the survi-
ors experienced rapid onset of pacing and offset of action
nd accurate endograft deployment.
ONCLUSIONS
PAC-directed right RV pacing is an effective method
f inducing hypotension, enables precise thoracic en-
ograft deployment, and safe balloon dilation after de-
loyment. It avoids femoral venous access and its poten-
ial complications, and simplifies the procedure by using
esources readily available to the vascular surgeon. This
echnique can be done with short pacing intervals, and
llows rapid recovery to baseline heart rate and mean
rterial pressure.
Despite these advantages, patient selection and appro-
riate expertise is crucial to avoid intraoperative complica-
ions. Patients with poor tolerance to tachycardia, de-
reased myocardial reserve, or severe coronary artery or
alvular disease, congestive heart failure, hypertrophic car-
iomyopathy, and severe valvular heart disease may be at
igh risk for complications.
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